A Bruet

Pyoderma gangrenosum: Classification and management

Updated Clinical Classification of Pulmonary Hypertension

Pyoderma gangrenosum, polycythemia rubra vera, and the development of leukemia

Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria

Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: Results of a multicenter, prospective, open‐label study of twenty‐two patients

Updated Clinical Classification of Pulmonary Hypertension

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Polyarteritis nodosa: A contemporary overview

Long-term patient survival in ANCA-associated vasculitis

Immunosuppressive therapy in lupus‐ and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty‐three cases

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

An approach to the diagnosis and management of systemic vasculitis

Interventions for renal vasculitis in adults

Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis

Pyoderma gangrenosum et maladie de Vaquez compliquée de myélofibrose A propos d'une observation chez un patient de 75 ans

Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: A prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty‐five patients